GMPSOP

OCTOBER 26, 2022

Table of Contents What is the concept of validation in pharmaceutical industry? ” Validation is a critical concept in the pharmaceutical industry. .” ” Validation is a critical concept in the pharmaceutical industry. Additional documents included each month. All written and updated by GMP experts.

Documentation 52

Documentation Method Validation Packaging Pharmaceutical Companies 52

pharmaphorum

OCTOBER 27, 2022

The overarching principle set out in Codes of Practice, and in particular the Principles for the use of digital channels in the EFPIA Code , is that the legislation and Codes of Practice apply equally to communications by companies on social media and digital channels. What are the key points from the Guidance?

Communication 93

Communication Pharmaceutical Manufacturing Packaging Documentation 93

Pharma Pathway

FEBRUARY 2, 2023

Should have exposure in preparing and drawing documents like PDR, MFR, BMR and execution of pilot and pivotal batches. Should have Excellent Oral and written communication and presentation skills. Our focus is primarily on niche therapeutic areas and complex products.

Dosage 59

Dosage Documentation Communication Pharmaceutical Companies 59

Pharmaceutical Technology

APRIL 18, 2023

Pharmaceutical companies and organisations get access to large amounts of data related to patients, clinical trials, and regulatory affairs. The companies help to design, develop and scale marketing strategies to effectively transition into a digitalised future.

Documentation 52

Documentation Pharmaceutical Companies Pharmaceutical Companies Communication 52

PharmaState Academy

MARCH 12, 2023

A white paper (sometimes called as whitepaper) is an information document issued by an organization to highlight the solution to a problem the functionality of a solution, good, or service. What necessitates the Government of India to evolve this voluntary Uniform Code of Pharmaceutical Marketing Practices (UCPMP) into an Act?

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Hospitals Communication 52

European Pharmaceutical Review

SEPTEMBER 26, 2023

Pharmaceutical companies regularly transfer databases as they shift to new systems or change service providers in pursuit of higher quality and increased efficiency. Any discrepancies should be documented using a Known Difference document and the solutions or acceptance of the discrepancy are then agreed upon.

Documentation 94

Documentation Data Entry Pharmaceutical Companies Pharmaceutical Companies 94

GMPSOP

APRIL 19, 2024

Spreadsheets with different levels of GAMP category GAMP 3: These spreadsheets are used solely to produce paper documents. Additional documents included each month. Develop necessary formulas in the spreadsheet Each formula described in the requirements documents must be embedded in the spreadsheet application. Subscribe iii.

Documentation 52

Documentation Data Entry Communication Pharmaceutical Companies 52

Pharmaceutical Technology

DECEMBER 15, 2022

In addition, several pieces of documentation will be required to support the API qualification, e.g. pharmacopeial compliance. It is also essential to evaluate the reliability of the company supplying the ingredient: do they provide sufficient communication and documentation? Is Benzalkonium Chloride a good choice?

Documentation 52

Documentation Compounding Communication Pharmaceutical Companies 52

Pharmaceutical Technology

JUNE 15, 2023

Artificial intelligence (AI) has many implications for pharmaceutical companies, including on research, drug discovery and development, manufacturing and trials. Colleagues with similar responsibilities and experience often work on the same team and may have limited communication with the rest of your organization.

Communication 52

Communication Documentation Pharmaceutical Companies Pharmaceutical Companies 52

pharmaphorum

OCTOBER 20, 2020

The pandemic has triggered a change in how pharmaceutical companies are engaging with healthcare professionals. When IQVIA polled non COVID-19 treating Italian HCPs in March when the crisis was at its worst, it asked HCPs if they still welcomed pharmaceutical company engagement during the crisis. The answer was yes.

Pharmaceutical Companies 122

Pharmaceutical Companies Pharmaceutical Companies Documentation Communication 122

pharmaphorum

JANUARY 27, 2023

Having previously spoken with Dr Mullen three years ago when she was country medical director for the UK & Ireland at GSK – on the topic of patient centricity and embedding that focus within the core of a pharmaceutical company – our recent interview provided some interesting insights into the changing landscape of the industry.

Vaccines 105

Vaccines Pharmaceutical Companies Pharmaceutical Companies Documentation 105

Viseven

SEPTEMBER 14, 2023

Hidden expenses can pile up, spiraling out of control due to many reasons related to supplier performance: the lack of appropriate documentation, storage, wrong dosage forms, and the list goes on. Technologies allow pharmaceutical companies to collect and analyze a massive amount of data to ensure proper drug safety.

Packaging 52

Packaging Pharmaceutical Companies Pharmaceutical Companies Dosage 52

Pharmaceutical Technology

APRIL 27, 2023

Consent to begin “Informed consent documents are created to explain to a patient how a trial is going to be run, what they can expect, and the associated risks and potential benefits,” says Jill Balcerzak, Vice President of Global Solutions at content and translations solution provider RWS. The result?

Documentation 52

Documentation Communication Pharmaceutical Companies Pharmaceutical Companies 52

Pharmaceutical Technology

MAY 23, 2023

In April, the pilot-level Nordic Pharmaceutical Forum (NPF) initiative, representing Finland, Iceland, Norway, Sweden, and Denmark, released an updated strategy document outlining the region’s plans to establish a joint procurement mechanism for medicines, with a declared focus on advanced therapy medicinal products (ATMPs) such as gene therapies.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Documentation Communication 52

pharmaphorum

OCTOBER 28, 2020

A 2020 survey from DrugsDisclosed.com of 3,346 users of prescription and over the counter (OTC) medicines from the UK and the Nordics revealed that: more than three-quarters of patients do not trust advice from pharmaceutical companies about their medication; 81% feel the pharmaceutical industry influences prescription decisions; and.

Vaccines 119

Vaccines Hospitals Pharmaceutical Companies Pharmaceutical Companies 119

GMPSOP

MARCH 20, 2024

Additional documents included each month. Additional documents included each month. You should identify and document the instrument ID, date and time of calibration, units of measurement, the standards used, the steps taken during calibration, and environmental conditions. Additional documents included each month.

Documentation 52

Documentation Pharmaceutical Manufacturing Labelling Communication 52

Viseven

JULY 11, 2023

Solutions for Pharma Enhance Patient Services solution allows pharmaceutical companies to establish closer relationships with patients and providers using a single platform to deliver personalized engagement and support programs for better adherence with automated workflows. Salesforce Healthcare Benefits – Are They Real?

Health and Personal Care Stores 40

Health and Personal Care Stores Insurance Coverage and Processing Scheduling Appointments Communication 40

European Pharmaceutical Review

JANUARY 25, 2024

These standardised documents provide meticulously curated and scientifically approved information. 7 Access to digital communications also remains a challenge in some Member States especially for those groups at risk of poverty and social exclusion (7.6 percent as EU average with some Member States as high as 25 percent).

Packaging 84

Packaging Documentation Communication Pharmaceutical Companies 84

Pharmaceutical Technology

JUNE 15, 2023

But before pharmaceutical companies can go to market with a breakthrough drug, they need to ensure safety and efficacy through clinical trials. For example, important information may be locked in knowledge silos or gained through experience, making it difficult to find or document.

Drug Development 52

Drug Development Compounding Adverse Reactions Dosage 52

pharmaphorum

OCTOBER 5, 2021

On the patient-facing side, you can adopt wearable, connected devices or ePRO strategies for remote patient monitoring, to ensure the treatment team has well-documented patient information between visits, or you can delve into digital therapeutics. About the author.

Hospitals 129

Hospitals Documentation Diabetes Communication 129

Pharmaceutical Technology

MAY 5, 2023

Today, software companies know there is a growing market to meet demand for supply chain visibility platforms. The question for pharmaceutical companies is how they can best deploy their data to make supply chains more efficient. Another important thing is that manual evaluations have been reduced to less than 0.5%

Pharmaceutical Companies 59

Pharmaceutical Companies Pharmaceutical Companies Documentation Communication 59

GMPSOP

JULY 31, 2023

The FDA sets stringent requirements for operational qualification for critical equipment and systems to ensure the safety and efficacy of pharmaceutical products. These requirements mandate that pharmaceutical companies thoroughly document OQ protocols, testing methods, acceptance criteria, and results.

Documentation 52

Documentation Dosage Labelling Data Entry 52

Pharmaceutical Technology

JUNE 8, 2023

Of the world’s 20 largest pharmaceutical companies, 17 have launched programmes tailored towards increasing medication access in low- and middle-income countries – up from just eight in 2010. Figure 1: Social media posts from pharmaceutical firms mentioning “environment”. A similar theme is evident in company filings.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Documentation Communication 52

Eye on FDA

AUGUST 2, 2022

There are two means of gaining insight into the agency’s thinking about regulatory issues related to promotional communications by pharmaceutical companies; one is through the issuance of guidance documents, the other is through enforcement. In 1998, there were 156 letters issued in a single year.

Communication 88

Communication Pharmaceutical Companies Pharmaceutical Companies Documentation 88

Eye on FDA

JULY 7, 2020

In the now distant past, enforcement from this office, then called the Division of Drug Marketing, Advertising, and Communications (DDMAC) and later re-named OPDP, was robust, with the office issuing scores of letters a year (156 were issued in 1998). One of them was about the appropriate use of links.

Communication 52

Communication Documentation Labelling Pharmaceutical Companies 52